NCT00955760View on ClinicalTrials.gov

Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Healthy
Interventions
DRUG

Neramexane

Drug-Drug Interaction Study

Trial Locations (1)

89231

AAIPharma Deutschland gmbH & Co. KG, Neu-Ulm

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00955760 - Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate | Biotech Hunter | Biotech Hunter